Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge (Q33187534)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

23 July 2017

Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge (English)

1 reference

Europe PubMed Central

23 July 2017

0 references

Daniel S Lorrain

1

object named as

Daniel S Lorrain

1 reference

Europe PubMed Central

23 July 2017

author name string

Hervé Schaffhauser

2

1 reference

Europe PubMed Central

23 July 2017

Una C Campbell

3

1 reference

Europe PubMed Central

23 July 2017

Christopher S Baccei

4

1 reference

Europe PubMed Central

23 July 2017

Lucia D Correa

5

1 reference

Europe PubMed Central

23 July 2017

Blake Rowe

6

1 reference

Europe PubMed Central

23 July 2017

Dana E Rodriguez

7

1 reference

Europe PubMed Central

23 July 2017

Jeffery J Anderson

8

1 reference

Europe PubMed Central

23 July 2017

Mark A Varney

9

1 reference

Europe PubMed Central

23 July 2017

Anthony B Pinkerton

10

1 reference

Europe PubMed Central

23 July 2017

Jean-Michel Vernier

11

1 reference

Europe PubMed Central

23 July 2017

Linda J Bristow

12

1 reference

Europe PubMed Central

23 July 2017

language of work or name

0 references

publication date

25 June 2003

1 reference

Europe PubMed Central

23 July 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

23 July 2017

28

1 reference

Europe PubMed Central

23 July 2017

1622-1632

1 reference

Europe PubMed Central

23 July 2017

9

1 reference

Europe PubMed Central

23 July 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300238

0 references

Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

α 2 -Adrenoceptor-Mediated Hyperpolarization of Locus Coeruleus Neurons: Intracellular Studies in Vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Plasma norepinephrine in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Noradrenergic mechanisms in stress and anxiety: II. Clinical studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Efferent connections of the medial prefrontal cortex in the rabbit.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Librium prevents the analgesia and shuttlebox escape deficit typically observed following inescapable shock.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Modulation of excitatory synaptic transmission in locus coeruleus by multiple presynaptic metabotropic glutamate receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

The hippocampus as a possible site of action for increased locomotion during intracerebral infusions of norepinephrine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Effects of sedatives on noradrenaline release from the medial prefrontal cortex in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Inhibitory effect of clonidine on ketamine-induced norepinephrine release from the medial prefrontal cortex in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Pharmacological properties of native metabotropic glutamate receptors in freshly dissociated Golgi cells of the rat cerebellum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Schizophrenia: elevated cerebrospinal fluid norepinephrine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Destruction of the locus coeruleus decreases physical signs of opiate withdrawal.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Single unit activity of locus coeruleus neurons in the freely moving cat. II. Conditioning and pharmacologic studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

II. New evidence for a locus coeruleus-norepinephrine connection with anxiety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Behavioral activation of rats during intraventricular infusion of norepinephrine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Efferent projections of the infralimbic (area 25) region of the medial prefrontal cortex in the rat: an anterograde tracer PHA-L study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Involvement of the brain noradrenaline system in emotional changes caused by stress in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

7 January 2021

based on heuristic

inferred from DOI database lookup

Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

7 January 2021

based on heuristic

inferred from DOI database lookup

Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300238

1 reference

Europe PubMed Central

23 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

23 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33187534&oldid=1537403019"